IBDEI0XY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16529,0)
 ;;=463.^^84^987^68
 ;;^UTILITY(U,$J,358.3,16529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16529,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,16529,1,4,0)
 ;;=4^Tonsillitis, Acute
 ;;^UTILITY(U,$J,358.3,16529,2)
 ;;=Tonsillitis, Acute^2695
 ;;^UTILITY(U,$J,358.3,16530,0)
 ;;=465.9^^84^987^69
 ;;^UTILITY(U,$J,358.3,16530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16530,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,16530,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,16530,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,16531,0)
 ;;=478.30^^84^987^72
 ;;^UTILITY(U,$J,358.3,16531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16531,1,3,0)
 ;;=3^478.30
 ;;^UTILITY(U,$J,358.3,16531,1,4,0)
 ;;=4^Vocal Cord Paralysis
 ;;^UTILITY(U,$J,358.3,16531,2)
 ;;=Vocal Cord Paralysis^127133
 ;;^UTILITY(U,$J,358.3,16532,0)
 ;;=018.90^^84^987^27
 ;;^UTILITY(U,$J,358.3,16532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16532,1,3,0)
 ;;=3^018.90
 ;;^UTILITY(U,$J,358.3,16532,1,4,0)
 ;;=4^Miliary TB
 ;;^UTILITY(U,$J,358.3,16532,2)
 ;;=^122716
 ;;^UTILITY(U,$J,358.3,16533,0)
 ;;=137.0^^84^987^31
 ;;^UTILITY(U,$J,358.3,16533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16533,1,3,0)
 ;;=3^137.0
 ;;^UTILITY(U,$J,358.3,16533,1,4,0)
 ;;=4^Old TB
 ;;^UTILITY(U,$J,358.3,16533,2)
 ;;=Late Effect of TB^266974
 ;;^UTILITY(U,$J,358.3,16534,0)
 ;;=010.00^^84^987^61
 ;;^UTILITY(U,$J,358.3,16534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16534,1,3,0)
 ;;=3^010.00
 ;;^UTILITY(U,$J,358.3,16534,1,4,0)
 ;;=4^Primary TB Infection
 ;;^UTILITY(U,$J,358.3,16534,2)
 ;;=^265990
 ;;^UTILITY(U,$J,358.3,16535,0)
 ;;=011.90^^84^987^67
 ;;^UTILITY(U,$J,358.3,16535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16535,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,16535,1,4,0)
 ;;=4^TB, Active
 ;;^UTILITY(U,$J,358.3,16535,2)
 ;;=TB, Active^122756
 ;;^UTILITY(U,$J,358.3,16536,0)
 ;;=010.10^^84^987^66
 ;;^UTILITY(U,$J,358.3,16536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16536,1,3,0)
 ;;=3^010.10
 ;;^UTILITY(U,$J,358.3,16536,1,4,0)
 ;;=4^TB Pleurisy
 ;;^UTILITY(U,$J,358.3,16536,2)
 ;;=TB Pleurisy^265999
 ;;^UTILITY(U,$J,358.3,16537,0)
 ;;=491.22^^84^987^10
 ;;^UTILITY(U,$J,358.3,16537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16537,1,3,0)
 ;;=3^491.22
 ;;^UTILITY(U,$J,358.3,16537,1,4,0)
 ;;=4^COPD w/ Acute Bronchitis
 ;;^UTILITY(U,$J,358.3,16537,2)
 ;;=^331455
 ;;^UTILITY(U,$J,358.3,16538,0)
 ;;=795.51^^84^987^60
 ;;^UTILITY(U,$J,358.3,16538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16538,1,3,0)
 ;;=3^795.51
 ;;^UTILITY(U,$J,358.3,16538,1,4,0)
 ;;=4^Positive PPD
 ;;^UTILITY(U,$J,358.3,16538,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,16539,0)
 ;;=031.9^^84^987^4
 ;;^UTILITY(U,$J,358.3,16539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16539,1,3,0)
 ;;=3^031.9
 ;;^UTILITY(U,$J,358.3,16539,1,4,0)
 ;;=4^Atypical Mycobacteria
 ;;^UTILITY(U,$J,358.3,16539,2)
 ;;=^123817
 ;;^UTILITY(U,$J,358.3,16540,0)
 ;;=480.0^^84^987^37
 ;;^UTILITY(U,$J,358.3,16540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16540,1,3,0)
 ;;=3^480.0
 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
 ;;=4^Pneumonia d/t Adenovirus
 ;;^UTILITY(U,$J,358.3,16540,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,16541,0)
 ;;=480.1^^84^987^52
 ;;^UTILITY(U,$J,358.3,16541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16541,1,3,0)
 ;;=3^480.1
 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
 ;;=4^Pneumonia d/t Resp Syncyt Virus
 ;;^UTILITY(U,$J,358.3,16541,2)
 ;;=^265792
 ;;^UTILITY(U,$J,358.3,16542,0)
 ;;=480.2^^84^987^50
 ;;^UTILITY(U,$J,358.3,16542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16542,1,3,0)
 ;;=3^480.2
 ;;^UTILITY(U,$J,358.3,16542,1,4,0)
 ;;=4^Pneumonia d/t Parainflu Virus
 ;;
 ;;$END ROU IBDEI0XY
